(818) 356-8248 info@theacrm.com

Heart Disease

Below is a sample of existing clinical evidence:
“HUCB-derived MSCs have been shown to regenerate into cardiomyocytes in vitro… This study supports IV administration as an adequate strategy for HUCB (Human Umbilical Cord Blood) cell transplantation, allowing effective migration of the cells to the area of injury where they subsequently induce autologous differentiation for repair of infarcted myocardium.”

– “Human Umbilical Cord Blood for Transplantation Therapy in Myocardial Infarction,” Acosta et al, Journal of Stem Cell Research & Therapy, 2013

For further information regarding regenerative medicine, please refer to information provided by American Academy of Integrative Cell Therapy (AAICT).

Visit AAICT